title: Contribution of MHC class I region to genetic susceptibility for giant cell arteritis.
abstract: OBJECTIVE
  The aim of this study was to assess the potential contribution of HLA-class I MICA and HLA-B gene polymorphisms towards the pathogenesis of giant cell arteritis (GCA).
  
  
  METHODS
  Ninety-eight biopsy-proven GCA patients and 225 ethnically matched controls from Lugo, Northwest Spain, were genotyped for the MICA-TM microsatellite polymorphism using a polymerase chain reaction (PCR)-based method. Genotyping of HLA-B was performed using PCR and detection with a reverse sequence-specific oligonucleotide (SSO) probes system.
  
  
  RESULTS
  A significant difference in the distribution of the alleles of MICA between patient and control groups (P = 0.005) was found. This was due to an increased frequency of the MICA A5 allele in GCA patients compared with controls (26 vs 13.6%; P = 0.0001; P(C) = 0.0005; OR 2.2, 95% CI 1.4-3.4). In addition, the HLA-B*15 allele showed a higher frequency in GCA patients compared with controls (P = 0.004; P(C) = 0.04; OR 2.7, 95% CI 1.3-5.7). Interestingly, the association observed with the MICA A5 allele seems to be independent of linkage disequilibrium with HLA-B, as well as independent of that previously described with HLA-DRB1*04. Remarkably, simultaneous presence of MICA A5 and HLA-B*15 or HLA-DRB1*04 genetic markers leads to an increase in the OR obtained for each individual genetic marker (MICA A5 + B*15 OR 3.2; MICA A5 + DRB1*04 OR 5.8).
  
  
  CONCLUSIONS
  Our results provide the first evidence that the MICA and HLA-B genes are independently associated with the genetic susceptibility to GCA, and suggest that several genes within the MHC might have independent effects in the susceptibility to this systemic vasculitis.
authors.affiliation: Division of Rheumatology, Hospital Xeral-Calde, Lugo, Spain.
authors.forename: M A
authors.initials: MA
authors.lastname: Gonzalez-Gay
authors.forename: B
authors.initials: B
authors.lastname: Rueda
authors.forename: J R
authors.initials: JR
authors.lastname: Vilchez
authors.forename: M A
authors.initials: MA
authors.lastname: Lopez-Nevot
authors.forename: G
authors.initials: G
authors.lastname: Robledo
authors.forename: M P
authors.initials: MP
authors.lastname: Ruiz
authors.forename: O
authors.initials: O
authors.lastname: Fernández
authors.forename: C
authors.initials: C
authors.lastname: Garcia-Porrua
authors.forename: M F
authors.initials: MF
authors.lastname: Gonzalez-Escribano
authors.forename: J
authors.initials: J
authors.lastname: Martín
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D005787:Gene Frequency; D005805:Genes, MHC Class I; D020022:Genetic Predisposition to Disease; D005838:Genotype; D013700:Giant Cell Arteritis / Q000235:genetics*; D015235:HLA-B Antigens / Q000235:genetics; D059910:HLA-B15 Antigen; D006684:HLA-DR Antigens / Q000235:genetics; D059811:HLA-DRB1 Chains; D015395:Histocompatibility Antigens Class I / Q000235:genetics; D006801:Humans; D008297:Male; D018895:Microsatellite Repeats / Q000235:genetics; D008875:Middle Aged
chemical_list: D015235:HLA-B Antigens; D059910:HLA-B15 Antigen; D006684:HLA-DR Antigens; D059811:HLA-DRB1 Chains; D015395:Histocompatibility Antigens Class I; C099187:MHC class I-related chain A